|
|
???tair.name??? >
???browser.page.title.author???
|
"liu tw"???jsp.browse.items-by-author.description???
Showing items 1-25 of 137 (6 Page(s) Totally)
1 2 3 4 5 6 > >>
View [10|25|50] records per page
| 國家衛生研究院 |
2023-10 |
Impact of pathological nodal staging and tumour differentiation on survival and postoperative radiotherapy in completely resected stage IIIA Non-small-cell lung cancer
|
Ku, HY;Lin, SM;Wang, CL;Lo, YTC;Chang, CS;Chang, GC;Ch'ang, HJ;Liu, TW |
| 國家衛生研究院 |
2023-06 |
Atezolizumab plus bevacizumab for patients with unresectable hepatocellular carcinoma and high hepatitis B viral load: Focusing on hepatic safety and viral kinetics
|
Chen, SC;Tsou, HHS;Lee, TY;Wang, HW;Chen, YH;Wang, TE;Su, YY;Yang, S;Chiu, CF;Liu, TW;Cheng, AL;Chen, LT;Hsu, C |
| 國家衛生研究院 |
2023-04-25 |
Prevalence of comorbidities and their impact on survival among older adults with the five most common cancers in Taiwan: a population study
|
Chien, LH;Tseng, TJ;Chen, TY;Chen, CH;Chen, CY;Jiang, HF;Tsai, FY;Ku, HY;Jiang, SS;Hsiung, CA;Liu, TW;Chang, IS |
| 國家衛生研究院 |
2023-04-11 |
Carbohydrate antigen 19-9 response to initial adjuvant chemotherapy predicts survival and failure pattern of resected pancreatic adenocarcinoma but not which patients are suited for additional adjuvant chemoradiation therapy: From a prospective randomized
|
Chiu, YF;Liu, TW;Shan, YS;Chen, JS;Li, CP;Ho, CL;Hsieh, RK;Hwang, TL;Chen, LT;Ch'ang, HJ; Taiwan Cooperative Oncology Group pancreatic cancer study group, |
| 國家衛生研究院 |
2023-03-17 |
Association of smoking and ALK tyrosine-kinase inhibitors on overall survival in treatment-naive ALK-positive advanced lung adenocarcinoma
|
Zheng, ZR;Ku, HY;Chen, KC;Chiang, CJ;Wang, CL;Chen, CY;Tsai, CM;Huang, MS;Yu, CJ;Chen, JS;Chou, TY;Lee, WC;Wang, CC;Liu, TW;Hsia, JY;Chang, GC |
| 國家衛生研究院 |
2023-02-28 |
Adjuvant chemotherapy compared with observation in patients with T2aN0 stage IB lung adenocarcinoma
|
Lee, PH;Chiang, CJ;Tseng, JS;Zheng, ZR;Chen, KC;Chu, CH;Huang, YH;Hsu, KH;Lee, WC;Yang, TY;Liu, TW;Hsia, JY;Chang, GC |
| 國家衛生研究院 |
2022-12-31 |
Secular trends of clinical characteristics and survival of hepatocellular carcinoma in Taiwan from 2011 to 2019
|
Kee, KM;Chen, CH;Hu, JT;Huang, YH;Wang, TE;Chau, GY;Chen, KH;Chen, YL;Lin, CC;Hung, CF;Huang, SF;Liu, TW;Ku, HY;Huang, BS;Wang, YP;Tseng, HP;Chiang, CJ;Lu, SN |
| 國家衛生研究院 |
2022-12 |
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high risk, early breast cancer
|
Geyer, CE, Jr.;Garber, JE;Gelber, RD;Yothers, G;Taboada, M;Ross, L;Rastogi, P;Cui, K;Arahmani, A;Aktan, G;Armstrong, AC;Arnedos, M;Balmaña, J;Bergh, J;Bliss, J;Delaloge, S;Domchek, SM;Eisen, A;Elsafy, F;Fein, LE;Fielding, A;Ford, JM;Friedman, S;Gelmon, KA;Gianni, L;Gnant, M;Hollingsworth, SJ;Im, SA;Jager, A;Jóhannsson, Ó;Lakhani, SR;Janni, W;Linderholm, B;Liu, TW;Loman, N;Korde, L;Loibl, S;Lucas, PC;Marmé, F;Martinez de Dueñas, E;McConnell, R;Phillips, KA;Piccart, M;Rossi, G;Schmutzler, R;Senkus, E;Shao, Z;Sharma, P;Singer, CF;Španić, T;Stickeler, E;Toi, M;Traina, TA;Viale, G;Zoppoli, G;Park, YH;Yerushalmi, R;Yang, H;Pang, D;Jung, KH;Mailliez, A;Fan, Z;Tennevet, I;Zhang, J;Nagy, T;Sonke, GS;Sun, Q;Parton, M;Colleoni, MA;Schmidt, M;Brufsky, AM;Razaq, W;Kaufman, B;Cameron, D;Campbell, C;Tutt, ANJ |
| 國家衛生研究院 |
2022-11-14 |
Optimizing margin status for improving prognosis in patients with oral cavity squamous cell carcinoma: A retrospective study from the two highest-volume Taiwanese hospitals
|
Liao, CT;Lee, LY;Lee, SR;Ng, SH;Liu, TW;Chien, CY;Lin, JC;Wang, CP;Terng, SD;Hua, CH;Chen, TM;Chen, WC;Tsai, YT;Kang, CJ;Tsai, CY;Chu, YH;Lin, CY;Fan, KH;Wang, HM;Hsieh, CH;Yeh, CH;Lin, CH;Tsao, CK;Yen, TC;Cheng, NM;Fang, TJ;Huang, SF;Lee, LA;Fang, KH;Wang, YC;Lin, WN;Hsin, LJ;Wen, YW |
| 國家衛生研究院 |
2022-09-21 |
Recalibrating risk prediction models by synthesizing data sources: Adapting the lung cancer PLCO model for Taiwan
|
Chien, LH;Chen, TY;Chen, CH;Chen, KY;Hsiao, CF;Chang, GC;Tsai, YH;Su, WC;Huang, MS;Chen, YM;Chen, CY;Liang, SK;Chen, CY;Wang, CL;Hung, HH;Jiang, HF;Hu, JW;Rothman, N;Lan, Q;Liu, TW;Chen, CJ;Yang, PC;Chang, IS;Hsiung, CA |
| 國家衛生研究院 |
2022-09 |
A prospective phase II study of biweekly S-1, leucovorin, and gemcitabine in elderly patients with locally advanced or metastatic pancreatic adenocarcinoma – The Taiwan Cooperative Oncology Group T1217 study
|
Bai, LY;Li, CP;Shan, YS;Chuang, SC;Chen, JS;Chiang, NJ;Chen, YY;Tsou, HH;Chuang, MH;Chiu, CF;Liu, TW;Chen, LT |
| 國家衛生研究院 |
2022-07 |
Potential roles of gut microbiome in patients with hepatocellular carcinoma treated with immune checkpoint inhibitors
|
Su, YY;Lee, WH;Wang, JH;Wang, HW;Chen, TW;Chen, BB;Ho, HJ;Liu, TH;Chou, SC;Chen, BR;Liu, TW;Chen, LT;Wu, CY;Hsu, C |
| 國家衛生研究院 |
2022-03-01 |
Association of smoking with patient characteristics and outcomes in small cell lung carcinoma, 2011-2018
|
Tseng, JS;Chiang, CJ;Chen, KC;Zheng, ZR;Yang, TY;Lee, WC;Hsu, KH;Huang, YH;Liu, TW;Hsia, JY;Chang, GC |
| 國家衛生研究院 |
2022-02-01 |
A prospective phase II study of biweekly S-1, leucovorin and gemcitabine in elderly patients with locally advanced or metastatic pancreatic adenocarcinoma
|
Bai, LY;Li, CP;Shan, YS;Chuang, SC;Chen, JS;Chiang, NJ;Chen, YY;Tsou, HH;Chuang, MH;Chiu, CF;Liu, TW;Chen, LT |
| 國家衛生研究院 |
2021-11-30 |
Survival outcomes of management in metastatic gastric adenocarcinoma patients
|
Hu, HM;Tsai, HJ;Ku, HY;Lo, SS;Shan, YS;Chang, HC;Chao, Y;Chen, JS;Chen, SC;Chiang, CJ;Li, AF;Wang, HP;Wang, TE;Bai, LY;Wu, MS;Chen, LT;Liu, TW;Yang, YH |
| 國家衛生研究院 |
2021-10-19 |
Clinical outcomes of Taiwanese patients with resected oral cavity squamous cell carcinoma who underwent Reconstruction with free versus local flaps
|
Liao, CT;Wen, YW;Lee, SR;Ng, SH;Liu, TW;Tsai, ST;Tsai, MH;Lin, JC;Chien, CY;Lou, PJ;Wang, CP;Chu, PY;Leu, YS;Tsai, KY;Terng, SD;Chen, TM;Wang, CH;Chen, WC;Lee, LY;Lin, CY;Wang, HM;Fang, TJ;Huang, SF;Kang, CJ;Chang, KP;Yen, TC;Yang, LY;Lin, CH |
| 國家衛生研究院 |
2021-07-26 |
Cancer registry coding via hybrid neural symbolic systems in the cross-hospital setting
|
Dai, HJ;Yang, YH;Wang, TH;Lin, YJ;Lu, PJ;Wu, CY;Chang, YC;Lee, YQ;Zhang, YC;Hsu, YC;Wu, HH;Ke, CR;Huang, CJ;Wang, YT;Yang, SF;Hsiao, KC;Liu, KJ;Chen, LT;Chang, IS;Chao, KSC;Liu, TW |
| 臺大學術典藏 |
2021-07-07T02:40:09Z |
Cancer patterns in nasopharyngeal carcinoma multiplex families over 15 years
|
Yu, KJ; Hsu, WL; Chiang, CJ; Chen, TC; Liu, TW; PEI-JEN LOU; Diehl, S; Goldstein, AM; Chen, CJ; Wang, CP; Hildesheim, A |
| 國家衛生研究院 |
2021-05-26 |
Adequate surgical margins for oral cancer: A Taiwan cancer registry national database analysis
|
Lin, MC;Leu, YS;Chiang, CJ;Ko, JY;Wang, CP;Yang, TL;Chen, TC;Chen, CN;Chen, HL;Liao, CT;Tsai, ST;Lin, JC;Chu, PY;Tsai, KY;Tsai, MH;Huang, HC;Yang, MH;Wu, YH;Terng, SD;Chien, CY;Liu, TW;Lee, WC;Lou, PJ |
| 國家衛生研究院 |
2021-05-20 |
Long-term survival effect of the interval between postoperative chemotherapy and radiotherapy in patients with completely resected pathological n2 non-small-cell lung cancer
|
Lin, SM;Ku, HY;Hsu, CY;Wang, CL;Chang, GC;Chang, CS;Liu, TW |
| 國家衛生研究院 |
2021-05 |
High expression of krüppel-like factor 10 or Smad4 predicts clinical benefit of adjuvant chemoradiotherapy in curatively resected pancreatic adenocarcinoma: From a randomized phase III trial
|
Pen, SL;Shan, YS;Hsiao, CF;Liu, TW;Chen, JS;Ho, CL;Chou, WC;Hsieh, RK;Chen, LT;Ch'ang, HJ |
| 國家衛生研究院 |
2021-05 |
A phase 2 study of liposomal irinotecan with 5-fluorouracil and leucovorin in squamous cell carcinoma of head and neck or esophagus after prior platinum-based chemotherapy or chemoradiotherapy
|
Bai, LY;Yang, MH;Chiang, NJ;Wu, SY;Lin, CY;Lien, MY;Chen, JH;Chang, MH;Hsieh, CY;Hong, RL;Kao, HF;Ye, RH;Chen, SH;Hsiao, CF;Chen, LT;Liu, TW |
| 國家衛生研究院 |
2021-02-04 |
Adjuvant pertuzumab and trastuzumab in early HER2-positive breast cancer in the APHINITY trial: 6 years' follow-up
|
Piccart, M;Procter, M;Fumagalli, D;de Azambuja, E;Clark, E;Ewer, MS;Restuccia, E;Jerusalem, G;Dent, S;Reaby, L;Bonnefoi, H;Krop, I;Liu, TW;Pieńkowski, T;Toi, M;Wilcken, N;Andersson, M;Im, YH;Tseng, LM;Lueck, HJ;Colleoni, M;Monturus, E;Sicoe, M;Guillaume, S;Bines, J;Gelber, RD;Viale, G;Thomssen, C; the APHINITY Steering Committee and Investigators |
| 中山醫學大學 |
2021 |
Long-Term Survival Effect of the Interval between Postoperative Chemotherapy and Radiotherapy in Patients with Completely Resected Pathological N2 Non-Small-Cell Lung Cancer
|
Lin, SM; Ku, HY; Hsu, CY; Wang, CL; Chang, GC; Chang, CS; Liu, TW |
| 國家衛生研究院 |
2020-02-18 |
Impacts of intralipid on nanodrug abraxane therapy and on the innate immune system
|
Chen, YJ;Tsai, CY;Cheng, YM;Nieh, SW;Yeh, TK;Chen, CP;Wang, MH;Chou, LH;Chiu, TY;Liu, L;Ho, C;Chen, CT;Liu, TW |
Showing items 1-25 of 137 (6 Page(s) Totally)
1 2 3 4 5 6 > >>
View [10|25|50] records per page
|
